Treating Adult-Onset Still Disease With Tocilizumab: A Case-Based Review

J Clin Rheumatol. 2021 Dec 1;27(8S):S414-S415. doi: 10.1097/RHU.0000000000001381.
No abstract available

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents* / adverse effects
  • Humans
  • Still's Disease, Adult-Onset* / diagnosis
  • Still's Disease, Adult-Onset* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab